In conclusion, MBL levels are significantly reduced following the initiation of insulin pump therapy in type 1 diabetic patients, despite a significant reduction in total insulin dose, but the change was not correlated with indicators of improved glycaemic control. This evidence concerns the gene MBL2 and type 1 diabetes mellitus.